<p><strong>Patients with Renal Impairment</strong>: No dosage adjustment is necessary for patients with renal impairment or for patients with end-stage renal disease (ESRD) undergoing hemodialysis.<br />
<br />
<strong>Patients with Hepatic Impairment</strong>: No dosage adjustment is necessary for patients with mild to moderate hepatic impairment. There are no clinical data in patients with severe hepatic impairment.</p>